Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PLX | BMY | AMGN | GILD | VRTX |
| Company | Protalix Biotherapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0900 | 72.07 | 245.00 | 61.00 | 288.65 |
| High | 1.1200 | 73.83 | 247.74 | 61.71 | 296.95 |
| Low | 1.0900 | 71.90 | 244.31 | 60.81 | 288.65 |
| Last | 1.1100 | 73.80 | 247.29 | 61.60 | 293.95 |
| Change | +0.0100 | +1.68 | +1.04 | +0.51 | +5.92 |
| % Change | +0.91% | +2.33% | +0.42% | +0.83% | +2.06% |
| Volume | 587,700 | 9,844,900 | 2,784,500 | 5,857,700 | 1,687,000 |
| 20-Day Average Volume | 114,485 | 9,118,395 | 2,473,000 | 6,320,650 | 1,466,540 |
| Previous Close | 1.1000 | 72.12 | 246.25 | 61.09 | 288.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0810 | 73.63 | 247.19 | 61.20 | 284.10 |
| 20-Day Raw Stochastic | 75.00% | 49.18% | 45.93% | 53.20% | 88.16% |
| 20-Day Relative Strength | 53.39% | 47.66% | 51.83% | 50.76% | 58.77% |
| Weighted Alpha | -29.80 | +12.00 | +10.10 | -12.50 | +53.60 |
| Today's Opinion | 32% Buy | 8% Buy | 100% Buy | 48% Sell | 100% Buy |
| Previous Opinion | 8% Buy | 8% Sell | 88% Buy | 80% Sell | 100% Buy |
| Last Month's Opinion | 72% Buy | 56% Buy | 80% Buy | 32% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.21% since 08/01/22 | +0.24% since 08/01/22 | +0.67% since 08/01/22 | +3.36% since 08/01/22 | +7.35% since 08/01/22 |
| Low | 1.0400 on 08/02/22 | 71.71 on 08/05/22 | 241.79 on 08/05/22 | 59.29 on 08/02/22 | 271.61 on 08/03/22 |
| High | 1.1400 on 08/05/22 | 74.73 on 08/02/22 | 249.33 on 08/03/22 | 63.65 on 08/03/22 | 296.95 on 08/08/22 |
| 1-Month | |||||
| %Chg | unch since 07/08/22 | -2.10% since 07/08/22 | -0.48% since 07/08/22 | -1.97% since 07/08/22 | -0.12% since 07/08/22 |
| Low | 1.0200 on 08/01/22 | 71.71 on 08/05/22 | 241.79 on 08/05/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 1.1400 on 08/05/22 | 75.99 on 07/11/22 | 253.76 on 07/26/22 | 63.65 on 08/03/22 | 296.95 on 08/08/22 |
| 3-Month | |||||
| %Chg | -2.20% since 05/06/22 | -3.74% since 05/06/22 | +4.56% since 05/06/22 | +0.69% since 05/06/22 | +15.76% since 05/06/22 |
| Low | 0.9829 on 05/12/22 | 71.71 on 08/05/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 233.01 on 05/11/22 |
| High | 1.2600 on 06/03/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 65.46 on 05/26/22 | 296.95 on 08/08/22 |
| 6-Month | |||||
| %Chg | -0.89% since 02/08/22 | +12.00% since 02/08/22 | +2.61% since 02/08/22 | -3.30% since 02/08/22 | +22.00% since 02/08/22 |
| Low | 0.7000 on 02/24/22 | 65.62 on 02/09/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 225.28 on 02/24/22 |
| High | 2.0000 on 04/04/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 296.95 on 08/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,769 | 153,994,592 | 131,546,752 | 76,625,984 | 73,665,400 |
| Shares Outstanding, K | 47,063 | 2,135,255 | 534,200 | 1,254,313 | 255,756 |
| Annual Sales | 38,350,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -27,580,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 16,090,000 | 11,887,000,000 | 6,238,000,000 | 6,590,000,000 | 2,097,500,000 |
| Last Quarter Net Income | -2,290,000 | 1,421,000,000 | 1,476,000,000 | 19,000,000 | 762,100,000 |
| 60-Month Beta | 1.84 | 0.40 | 0.56 | 0.34 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/16/22 | 1.93 on 07/27/22 | 4.65 on 08/04/22 | 1.58 on 08/02/22 | 3.60 on 08/04/22 |
| Latest Earnings Date | 08/15/22 | 07/27/22 | 08/04/22 | 08/02/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 06/30/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 08/17/22 | 09/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.34 | 13.77 | 8.79 | 21.41 |
